According to Perrigo's latest financial reports the company's current earnings (TTM) are $0.16 B. an increase over its 2022 earnings that were of $16.9 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.16 B | 879.88% |
2022 | $16.9 M | -95.6% |
2021 | $0.38 B | 999.43% |
2020 | $34.9 M | -88.56% |
2019 | $0.30 B | -27.55% |
2018 | $0.42 B | -7.14% |
2017 | $0.45 B | -109.71% |
2016 | -$4.68 B | -1173.64% |
2015 | $0.43 B | -33.72% |
2014 | $0.65 B | -0.51% |
2013 | $0.65 B | 4.1% |
2012 | $0.63 B | 24.1% |
2011 | $0.51 B | 23.74% |
2010 | $0.41 B | 48.38% |
2009 | $0.27 B | 13.35% |
2008 | $0.24 B | 63.81% |
2007 | $0.14 B | 32.73% |
2006 | $0.11 B | 56.84% |
2005 | $71.97 M | -19.63% |
2004 | $89.55 M | -3.93% |
2003 | $93.21 M | -8.39% |
2002 | $0.10 B | 49.64% |
2001 | $68 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | $1.43 B | 769.44% | ๐บ๐ธ USA |
Endo International
ENDPQ | -$2.4 B | -1,544.40% | ๐ฎ๐ช Ireland |
Intercept Pharmaceuticals
ICPT | -$58.01 M | -135.03% | ๐บ๐ธ USA |
Catalent CTLT | -$1.21 B | -828.86% | ๐บ๐ธ USA |